ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Cyclo Therapeutics Inc

Cyclo Therapeutics Inc (CYTH)

1.30
0.00
(0.00%)
Closed April 25 4:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.30
Bid
1.25
Ask
1.33
Volume
-
0.00 Day's Range 0.00
0.6801 52 Week Range 2.57
Market Cap
Previous Close
1.30
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
96,836
Shares Outstanding
22,732,402
Dividend Yield
-
PE Ratio
-1.47
Earnings Per Share (EPS)
-0.88
Revenue
1.08M
Net Profit
-20.06M

About Cyclo Therapeutics Inc

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquapl... Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Gainesville, Florida, USA
Founded
1970
Cyclo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CYTH. The last closing price for Cyclo Therapeutics was $1.30. Over the last year, Cyclo Therapeutics shares have traded in a share price range of $ 0.6801 to $ 2.57.

Cyclo Therapeutics currently has 22,732,402 shares outstanding. The market capitalization of Cyclo Therapeutics is $29.55 million. Cyclo Therapeutics has a price to earnings ratio (PE ratio) of -1.47.

CYTH Latest News

Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Continued progress of pivotal Phase 3 study (TransportNPC™) evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) toward 48-week comparative interim analysis data...

Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and...

Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results

Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.18.333333333331.21.321.1450461.22301041CS
4-0.08-5.797101449281.381.791.11051291.39060824CS
12-0.6-31.57894736841.91.921.1968361.53667728CS
260.2928.71287128711.012.1150.89241019351.55811409CS
520.466455.95009596930.83362.570.6801978181.51252218CS
156-5.82-81.74157303377.12130.671015064.36775658CS
260-3.05-70.11494252874.3517.750.672283256.38285113CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0

CYTH Discussion

View Posts
Lazarus Lazarus 1 month ago
The stock was 10X+ higher when it went from the OTC to the NAZ --> basically been downhill ever since.
👍️0
Monksdream Monksdream 1 month ago
CYTH under $2
👍️0
Monksdream Monksdream 2 months ago
CYTH under $2
👍️0
TheFinalCD TheFinalCD 3 months ago
$CYTH NEWS https://finviz.com/quote.ashx?t=CYTH&ty=c&ta=1&p=d

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office $CYTH https://t.co/RkXNroh4eF— Health Stocks News (@health_stocks) January 29, 2024
👍️0
Awl416 Awl416 4 months ago
Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
👍️0
Monksdream Monksdream 7 months ago
CYTH under $2
👍️0
Lazarus Lazarus 1 year ago
Price has been cut in half since you declared it "underpriced"
👍️0
Covid19freak Covid19freak 1 year ago
(CYTH) $1.90 ..MC $17 mil -has Orphan drug in Phase 3 and Alzheimer treatment in Phase 2b ...likely the most attractive and underpriced biotech in the sector .

Pipeline
https://cyclotherapeutics.com/pipeline/

Presentation
https://s3.amazonaws.com/b2icontent.irpass.cc/2573/187895.pdf
👍️0
Lazarus Lazarus 1 year ago
...but, but, but what about this??
👍️0
Esa Esa 2 years ago
Insiders buying and phase 3 data coming out soon, looking good for a little run
👍️0
scotsand scotsand 2 years ago
Picked some up today. Looks quite promising at these levels. GLTA
👍️0
XenaLives XenaLives 3 years ago

Trappsol® Cyclo™
A Potential Treatment for Serious Cholesterol Transport Diseases





The Role of Cholesterol in a Cell
Cholesterol is an essential component of the cell membrane, a structure which defines an individual cell in the body. It also plays a role in the production of important hormones, like testosterone and progesterone. Because cholesterol is so important to the normal function of our cells, its synthesis and degradation is tightly controlled by an array of cellular processes. When there is an imbalance in cholesterol synthesis or metabolism, cells and organs may not function properly, leading to disease or death.



The Harm Caused by a Cell’s Inability to Effectively Transport Cholesterol
As the body uses cholesterol to perform its necessary functions, it freely transports cholesterol in and out of the cell. However, when there is a defect in the Niemann-Pick gene, the cell is unable to transport cholesterol out of the lysomes, causing it to build up. This buildup of cholesterol inhibits other cell functions, essentially choking the cell, which leads to cell death, organ dysfunction and death.





The Science Behind Trappsol® Cyclo™
Trappsol®Cyclo™ is a proprietary formulation of hydroxypropyl beta cyclodextrin and in multiple clinical studies has shown encouraging results to effectively manage the transportation of cholesterol. Taking the place of the defective NPC1 protein, Trappsol® Cyclo™, with its cyclic structure, facilitates the transport of accumulated cholesterol out of cellular lysosomes so it can be further processed and excreted out of cells.

Trappsol® Cyclo™ is currently being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC), a rare, fatal and progressive genetic disorder and Alzheimer’s disease, an irreversible, progressive neurological disorder, in which high cholesterol is also implicated as a risk factor.

https://cyclotherapeutics.com/trappsol-cyclo/
👍️0
CYDYWinning CYDYWinning 3 years ago
Yup I purchased CYTHW as well. This looks like a very undervalued stock at this point.
👍️0
Esa Esa 3 years ago
Insider (director) buying under $7
👍️0
Esa Esa 3 years ago
Thinking of buying in here, overall company looks good, Mcap, Share structure and pipeline
👍️0
Pedro2004 Pedro2004 3 years ago
HOD $6.74 down to $5.60 stop-loss within 40 minutes.

Definitely a pump and dump


👍️0
Pedro2004 Pedro2004 3 years ago
Starting to wake-up.

Bought back-in 1,000 shares $6.48

Setting up a stop-loss to eat-up my gains on the first round.

I’m either going to break even, or make some money.
👍️0
Pedro2004 Pedro2004 3 years ago
Still trading like an OTC, Nevada Company, pump and dump.
👍️0
Pedro2004 Pedro2004 3 years ago
I thought this was going to run.
👍️0
Pedro2004 Pedro2004 3 years ago
Damn. My stop loss hit. Still made money.
👍️0
stockdawg44 stockdawg44 3 years ago
$5.70 CYTH, nice swing from low's....
👍️0
MAKESOME79 MAKESOME79 3 years ago
$CYTH #StocksToBuy #CYTH This #stock has only 1.2 mil outstanding shares. This just moved up from the OTC came to #NASDAQ on Dec 08. They did 1 for 100 reverse split. All insider buy were at 5.00 Warrent sell 6.50 Went from $5 to $11 Sell off now great entry 5.15 for Mon $12 Target
👍️0
ClayTrader ClayTrader 3 years ago
* * $CYTH Video Chart 12-18-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Awl416 Awl416 3 years ago
What a lovely swing this turned in too
👍️0
fwayneh1 fwayneh1 15 years ago
I think he meant CLTH.

If so, "yawnnnnnnn".
👍️0
thee trader thee trader 15 years ago
you should fix that
👍️0
thee trader thee trader 15 years ago
CYTH is the incorrect symbol
👍️0
pay in cash pay in cash 15 years ago
Is CYTH the right symbol? nothing comes up
👍️0
tradrdad45 tradrdad45 15 years ago
Biodiesel and Ethanol Investing » Biomass

Here's a great site for anyone interested in this sub-sector. It has all the latest news and research grants, etc. This is a booming field with many opportunities:

http://www.biodieselinvesting.com/biodiesel-archives/category/biomass/
👍️0
tradrdad45 tradrdad45 15 years ago
This company is on the forefront of the next generation in biofuels - a sector poised to explode in the next few years:

"Americans throw away over 250 million tons of garbage every year. Out of all that garbage, approximately 32 percent is recovered and recycled or composted, 14 percent is burned at combustion facilities, and the remaining 54 percent (or 135 million tons of garbage) is disposed of in landfills. Because of limited disposal options, many municipalities are forced to transport garbage from local transfer stations to available landfills over long distances as well as pay increasingly higher tipping fees for landfill operators to take their garbage. Landfill operators dispose of garbage by burying it under mounds of dirt where, over time, toxins in the garbage can leach into our water supplies, or by burning it in incinerators releasing many of the toxic materials in the garbage into the atmosphere. We have licensed and developed a group of technologies that used together can process municipal garbage into usable energy products. We use the cellulosic material in municipal garbage to make ethanol by first converting it into a sugar and water mixture. Our ethanol production technology uses a two-stage dilute acid hydrolysis process that recycles heat and acid from each stage of the process to efficiently make C5 and C6 sugars from cellulosic material. The resulting sugars are fermented and distilled into a fuel grade ethanol.

Good info here:

http://www.qualitystocks.net/messageboard/viewtopic.php?p=20309
👍️0
tradrdad45 tradrdad45 15 years ago
CleanTech BioFuels licensed technology

This is a very innovative approach that appears to have certain advantages over the microalgae-based approach of, for example, Algenol Biofuels and Aurora BioFuels. The process entails three stages:

Separation & Cleaning

PSC (Pressurized Stem Classification) Technology. Due to overstrained landfills, disposing of MSW is increasingly becoming a problem for many U.S. cities and regions. CleanTech has licensed the exclusive rights in the United States to a technology that can convert MSW into a biomass material that we refer to as Process Engineered Fuel (PEF), Patent No. 6,306,248 - October 23, 2001). Our process employs heat, steam and agitation to convert the raw MSW into an output stream with uniform moisture content and particle size, roughly the consistency of compost, while simultaneously cleaning the other fractions of the garbage and removing a substantial amount of the volatile organic compounds (VOC’s) from the garbage. However, while the output resembles compost, it is high in cellulose content, making it an excellent feedstock for conversion to ethanol.

Saccherafication Hydrolysis
Hydrolysis Technology. Further, CleanTech has licensed a patented (Patent No. 5,411,594 – May 2, 1995), proprietary technology capable of converting the PEF output from the PSC technology into a fermentable sugar stream. This process is a unique and improved variation of what is generally known as two-stage, lignocellulosic acid hydrolysis. Our unique version of this technology incorporates process improvements that reduce its operating costs to the extent anticipated to be cost-competitive with corn-based ethanol production. Additionally, we have entered into a letter of intent with HFTA, Inc. to license technology as described in U.S. Patents No. 5221357, 5366558, 5536325, 5628830, and 6019900 that utilize nitric acid for hydrolyzing cellulosic material rather than sulfuric or hydrochloric acid. The use of nitric acid for this process creates a number of efficiencies that we believe will make our system significantly more easy to commercialize compared to any other acid hydrolysis process in development. Currently, we are designing a system that integrates these processes together.
Fermentation
Fermentation. The final piece of the ethanol production system is the fermentation of the sugar stream into ethanol. We have identified a fermentation technology developed at Purdue University that will produce high yields of ethanol from the sugar stream output and are in the process of testing and licensing the Purdue technology.

Together these technologies represent an elegant and relatively simple method by which to solve the landfill scarcity problem while producing a very valuable output product, ethanol.


👍️0
tradrdad45 tradrdad45 15 years ago
CleanTech BioFuels management

These guys have the experience in finance and the securities industry to get the job done:

The Company is currently led by its Chief Executive Officer, Chief Financial Officer, and General Counsel:

Ed Hennessey. Mr. Hennessey is CEO and President of the Company. He also serves as Chairman of the Board of Directors of the Company. He has been President and CEO of CleanTech Biofuels and its predecessor companies, since 2002. He has developed the business strategy, and secured the existing technology licenses and the funding required to date. Prior to becoming involved in the waste-to-energy industry, Mr. Hennessey worked in the securities industry beginning with Shearson Lehman Brothers in 1986 and ultimately opening and managing his own securities brokerage and investment banking firm, which he sold in 1999.

Thomas Jennewein. Mr. Jennewein is Chief Financial Officer of the Company. Previously he served as Manager of Financial Reporting for the Maverick Tube Corporation and prior to that worked in a similar position for the Argosy Gaming Company. Mr. Jennewein began his career in 1985 as a Senior Auditor with Arthur Anderson & Company.

Michael D. Kime. Mr. Kime serves as General Counsel of the Company. Prior to joining the Company in 2007 he was a partner in the law firm of Sauerwein, Simon, Blanchard, & Kime, P.C. Mr. Kime has been a practicing attorney since 1994, focusing on securities law, finance, mergers and acquisitions. Mr. Kime also co-wrote and co-produced the award winning documentary, Can Mr. Smith Get to Washington Anymore?. Mr. Kime attended Louisiana State University Law School where he graduated ranked second in his class and served on the Louisiana Law Review.
👍️0
tradrdad45 tradrdad45 15 years ago
QualityStocks just came out with a nice report on CleanTech BioFuels:

CleanTech BioFuels, Inc. (CLTH) is focused on developing ground-breaking technologies to convert cellulosic material found in municipal solid waste (MSW) into ethanol. Out of the 250+ million tons of garbage disposed of each year in America, only 32% is recovered, 14% is burned at combustion facilities and the remaining 54% is tossed in landfills. However, using CleanTech’s technology, this unusable waste is a source of energy rather than a disposal problem.

The company holds exclusive licenses to a collection of technologies that offer substantial advantages in converting MSW into viable energy. CleanTech is also developing an exclusive license to produce ethanol from municipal garbage by utilizing a dilute acid hydrolysis process that transforms cellulosic feedstock into fermentable sugars. Together, these technologies will allow CleanTech to produce cellulosic ethanol from municipal garbage at low costs.

Because the company has such a unique method of solving disposal issues while also addressing our dependence on foreign oils, it has been presented with opportunities to joint venture, license or acquire other related technologies that can also be used to convert municipal garbage into energy. CleanTech anticipates developing other complementary technologies to convert even greater amounts of the municipal waste stream into clean fuels.

The demand for the production of ethanol has grown to incredible levels with the recent volatility in oil prices and recently enacted legislation requiring a production rate of 36 billion gallons of ethanol per year by 2022. Ethanol from agricultural products like corn and sugar cane isn’t expected to be able to meet this mandate, creating an even stronger demand for advanced biofuels such as cellulosic ethanol.

http://clth.qualitystocks.net/
👍️0
tradrdad45 tradrdad45 15 years ago
Greetings IHubbers!

We've all been waiting for cellulose-based ethanol to become a cost-efficient reality. CleanTech BioFuels (CLTH) is on the cutting edge of the biofuels revolution. They're using patented new technology developed at the University of California at Berkeley to efficiently produce ethanol from municipal solid waste converted into sugars from cellulosic material.

This could be a terrific ground floor opportunity; things are moving fast - this just in:

"CleanTech Biofuels Finalizes Transaction with World Waste Technologies ...

"--(USEquityNews)-- 10/29/2008 - (CLTH), formerly a sublicensee of World Waste Technologies' patent (U.S. Patent No. 6,306,248 ...), announces that it has acquired that patent. CleanTech Biofuels is now able to file new United States and international patents based on the combined technologies described in the patent and those of Biomass North America Licensing. CleanTech CEO, Ed Hennessey, noted, "We are very excited to have completed this transaction, as this acquisition creates many new opportunities for our company."

Here's some more details from a message board post:

"CleanTech has, for the first time, satisfactorily tested the technology and associated equipment for efficiently generating fermentable sugars from municipal solid waste. The patented technology uses nitric acid, versus the more common sulfuric or hydrochloric acid, for hydrolyzing cellulosic material. CleanTech believes that nitric acid hydrolysis represents the cutting edge of current technology in the cellulosic ethanol industry. These fermentable sugars can then be processed into ethanol.

"The advantages of turning waste directly into ethanol are significant:

"- It offers a non-fossil fuel source that has an already existing supplier, avoiding agricultural and food supply issues.
- It reduces pollution released into the environment by the disposal of municipal solid waste.
- It reduces the amount of material going into landfills by as much as eighty five percent.
- It generates biofuels and other usable energy products at competitive prices."
👍️0

Your Recent History

Delayed Upgrade Clock